top of page
The Mission
Key Opinion Leaders
International
Advisory Board
Initiatives
Discuss a case
Journal Scan
Latest News
Education Hub
Gallery
IBDENC ENC
Mar 2, 2022
PICaSSO Histologic Remission Index (PHRI) in ulcerative colitis
PICaSSO Histologic Remission Index (PHRI) in ulcerative colitis: development of a novel simplified histological score for monitoring...
0
IBDENC ENC
Feb 18, 2022
Immunomodulator withdrawal from anti-TNF therapy is not associated with loss of response in IBD
Immunomodulator withdrawal from anti-TNF therapy is not associated with loss of response in inflammatory bowel disease R. Mahmoud,J.P.D....
0
IBDENC ENC
Feb 17, 2022
SAFETY AND EFFECTIVENESS OF THE BNT162B2 MRNA COVID-19 VACCINE IN A NATIONWIDE COHORT OF PATIENTS
SAFETY AND EFFECTIVENESS OF THE BNT162B2 MRNA COVID-19 VACCINE IN A NATIONWIDE COHORT OF PATIENTS WITH INFLAMMATORY BOWEL DISEASE...
0
IBDENC ENC
Feb 16, 2022
The Crohn's disease exclusion diet for induction and maintenance of remission in adults with mild-to
The Crohn's disease exclusion diet for induction and maintenance of remission in adults with mild-to-moderate Crohn's disease (CDED-AD):...
0
IBDENC ENC
Feb 16, 2022
Accuracy of Gastrointestinal Ultrasound and Calprotectin in the Assessment of Inflammation
Accuracy of Gastrointestinal Ultrasound and Calprotectin in the Assessment of Inflammation and its Location in Patients with an Ileoanal...
0
IBDENC ENC
Feb 16, 2022
Twenty-first Century Trends in the Global Epidemiology of Pediatric-Onset IBD: Systematic Review
Twenty-first Century Trends in the Global Epidemiology of Pediatric-Onset Inflammatory Bowel Disease: Systematic Review M. Ellen...
0
IBDENC ENC
Feb 10, 2022
Effects of vitamin D supplementation on blood markers in ulcerative colitis patients: a systematic
Effects of vitamin D supplementation on blood markers in ulcerative colitis patients: a systematic review and meta-analysis. Guan Y, Hao...
0
IBDENC ENC
Feb 10, 2022
Disease Prognostic Biomarkers in Inflammatory Bowel Diseases—A Reality Check
Disease Prognostic Biomarkers in Inflammatory Bowel Diseases—A Reality Check Matthias Zilbauer, Robert Heuschkel Published in Journal of...
0
IBDENC ENC
Feb 4, 2022
Incidence, outcomes, and impact of COVID-19 on inflammatory bowel disease: propensity matched resea
Incidence, outcomes, and impact of COVID-19 on inflammatory bowel disease: propensity matched research network analysis Yousaf Hadi,...
0
IBDENC ENC
Feb 3, 2022
First-line treatment with infliximab versus conventional treatment in children with newly diagnosed
First-line treatment with infliximab versus conventional treatment in children with newly diagnosed moderate-to-severe Crohn’s disease:...
0
IBDENC ENC
Feb 2, 2022
Alcohol consumption and risk of inflammatory bowel disease among three prospective US cohorts
Alcohol consumption and risk of inflammatory bowel disease among three prospective US cohorts Kevin Casey, Emily W Lopes, Blake Niccum,...
0
IBDENC ENC
Jan 8, 2022
Short-term effectiveness and safety of tofacitinib in ulcerative colitis - real world data
Short-term effectiveness and safety of tofacitinib in ulcerative colitis - real world data from tertiary medical centers in Israel...
0
bottom of page